NEUROD1 and diabetes mellitus: In addition, mRNA expression levels related to β-cell differentiation and proliferation such as NeuroD, Nkx6.1 and Irs2 were significantly higher only in combination therapy in an early phase of diabetes (Fig. 6e–g).